Regulation of the bioavailability of TGF-β and TGF-β-related proteins

Cold Spring Harbor Perspectives in Biology

Volumn 8, Issue 6, 2016, Pages

  Robertson, Ian B ^a   Rifkin, Daniel B ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; FIBRILLIN; LATENT TRANSFORMING GROWTH FACTOR BETA BINDING PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL; BIOAVAILABILITY; EXTRACELLULAR MATRIX; GLYCOSYLATION; HUMAN; KNOCKOUT MOUSE; METABOLISM; MOUSE; PHYLOGENY; PHYSIOLOGY; PROTEIN DOMAIN; PROTEIN MULTIMERIZATION; SIGNAL TRANSDUCTION;

ANIMALS; BIOLOGICAL AVAILABILITY; CARRIER PROTEINS; EXTRACELLULAR MATRIX; FIBRILLINS; GLYCOSYLATION; HUMANS; LATENT TGF-BETA BINDING PROTEINS; MICE; MICE, KNOCKOUT; PHYLOGENY; PROTEIN DOMAINS; PROTEIN MULTIMERIZATION; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 84973161362     PISSN: None     EISSN: 19430264     Source Type: Journal    
DOI: 10.1101/cshperspect.a021907     Document Type: Article

References (210)

1. Abdelouahed M, Ludlow A, Brunner G, Lawler J. 2000. Activation of platelet-transforming growth factor b-1 in the absence of thrombospondin-1. J Biol Chem 275: 17933-17936.
2. Abdel-Wahab N, Wicks SJ, Mason RM, Chantry A. 2002. Decorin suppresses transforming growth factor-b-induced expression of plasminogen activator inhibitor-1 in human mesangial cells through a mechanism that involves Ca2þ-dependent phosphorylation of Smad2 at serine-240. Biochem J 362: 643-649.
3. Abe M, Oda N, Sato Y. 1998. Cell-associated activation of latent transforming growth factor-b by calpain. J Cell Physiol 174: 186-193.
4. Ahamed J, Burg N, Yoshinaga K, Janczak CA, Rifkin DB, Coller BS. 2008. In vitro and in vivo evidence for shearinduced activation of latent transforming growth factorb1. Blood 112: 3650-3660.
5. Akita K, Okuno M, Enya M, Imai S, Moriwaki H, Kawada N, Suzuki Y, Kojima S. 2002. Impaired liver regeneration in mice by lipopolysaccharide via TNF-a/kallikrein-mediated activation of latent TGF-β. Gastroenterology 123: 352-364.
6. Alcaraz LB, Exposito JY, Chuvin N, Pommier RM, Cluzel C, Martel S, Sentis S, Bartholin L, Lethias C, Valcourt U. 2014. Tenascin-X promotes epithelial-to-mesenchymal transition by activating latent TGF-β. J Cell Biol 205: 409-428.
7. Aluwihare P, Mu Z, Zhao Z, Yu D, Weinreb PH, Horan GS, Violette SM, Munger JS. 2009. Mice that lack activity of avb6-and avb8-integrins reproduce the abnormalities of Tgfb1-and Tgfb3-null mice. J Cell Sci 122: 227-232.
8. Amarnath S, Dong L, Li J, Wu Y, Chen W. 2007. Endogenous TGF-β activation by reactive oxygen species is key to Foxp3 induction in TCR-stimulated and HIV-1-infected human CD4þCD252 T cells. Retrovirology 4: 57.
9. Annes JP, Rifkin DB, Munger JS. 2002. The integrin aVb6 binds and activates latent TGFb3. FEBS Lett 511: 65-68.
10. Annes JP, Munger JS, Rifkin DB. 2003. Making sense of latent TGF-β activation. J Cell Sci 116: 217-224.
11. Annes JP, Chen Y, Munger JS, Rifkin DB. 2004. Integrin aVb6-mediated activation of latent TGF-β requires the latent TGF-β-binding protein-1. J Cell Biol 165: 723-734.
12. Anscher MS, Thrasher B, Rabbani Z, Teicher B, Vujaskovic Z. 2006. Antitransforming growth factor-b antibody 1D11 ameliorates normal tissue damage caused by high-dose radiation. Int J Radiat Oncol Biol Phys 65: 876-881.
13. Antonelli-Orlidge A, Saunders KB, Smith SR, D’Amore PA. 1989. An activated form of transforming growth factor b is produced by cocultures of endothelial cells and pericytes. Proc Natl Acad Sci 86: 4544-4548.
14. Arteaga-Solis E, Gayraud B, Lee SY, Shum L, Sakai L, Ramirez F. 2001. Regulation of limb patterning by extracellular microfibrils. J Cell Biol 154: 275-281.
15. Attur MG, Palmer GD, Al-Mussawir HE, Dave M, Teixeira CC, Rifkin DB, Appleton CT, Beier F, Abramson SB. 2009. F-spondin, a neuroregulatory protein, is up-regulated in osteoarthritis and regulates cartilage metabolism via TGF-β activation. FASEB J 23: 79-89.
16. Bailly S, Brand C, Chambaz EM, Feige JJ. 1997. Analysis of small latent transforming growth factor-b complex formation and dissociation by surface plasmon resonance. Absence of direct interaction with thrombospondins. J Biol Chem 272: 16329-16334.
17. Barcellos-Hoff MH. 1996. Latency and activation in the control of TGF-β. J Mamm Gland Biol Neoplasia 1: 353-363.
18. Barcellos-Hoff MH, Dix TA. 1996. Redox-mediated activation of latent transforming growth factor-b1. Mol Endocrinol 10: 1077-1083.
19. Barcellos-Hoff MH, Derynck R, Tsang ML, Weatherbee JA. 1994. Transforming growth factor-b activation in irradiated murine mammary gland. J Clin Invest 93: 892-899.
20. Bergaya S, Meneton P, Bloch-Faure M, Mathieu E, Alhenc-Gelas F, Levy BI, Boulanger CM. 2001. Decreased flowdependent dilation in carotid arteries of tissue kallikreinknockout mice. Circ Res 88: 593-599.
21. Bi Y, Stuelten CH, Kilts T, Wadhwa S, Iozzo RV, Robey PG, Chen XD, Young MF. 2005. Extracellular matrix proteoglycans control the fate of bone marrow stromal cells. J Biol Chem 280: 30481-30489.
22. Biswas S, Guix M, Rinehart C, Dugger TC, Chytil A, Moses HL, Freeman ML, Arteaga CL. 2007. Inhibition of TGF-β with neutralizing antibodies prevents radiation-induced acceleration of metastatic cancer progression. J Clin Invest 117: 1305-1313.
23. Blois SM, Sulkowski G, Tirado-Gonzalez I, Warren J, Freitag N, Klapp BF, Rifkin D, Fuss I, Strober W, Dveksler GS. 2013. Pregnancy-specific glycoprotein 1 (PSG1) activates TGF-β and prevents dextran sodium sulfate (DSS)-induced colitis in mice. Mucosal Immunol 7: 348-358.
24. Bouchard C, Galinha A, Tartour E, Fridman WH, Sautes C. 1995. A transforming growth factor b-like immunosuppressive factor in immunoglobulin G-binding factor. J Exp Med 182: 1717-1726.
25. Brophy TM, Coller BS, Ahamed J. 2013. Identification of the thiol isomerase-binding peptide, mastoparan, as a novel inhibitor of shear-induced transforming growth factor b1 (TGF-β 1) activation. J Biol Chem 288: 10628-10639.
26. Brown PD, Wakefield LM, Levinson AD, Sporn MB. 1990. Physicochemical activation of recombinant latent transforming growth factor-b’s 1, 2, and 3. Growth Factors 3: 35-43.
27. Brown MA, Zhao Q, Baker KA, Naik C, Chen C, Pukac L, Singh M, Tsareva T, Parice Y, Mahoney A, et al. 2005. Crystal structure of BMP-9 and functional interactions with pro-region and receptors. J Biol Chem 280: 25111-25118.
28. Brunner AM, Marquardt H, Malacko AR, Lioubin MN, Purchio AF. 1989. Site-directed mutagenesis of cysteine residues in the pro region of the transforming growth factor b1 precursor. Expression and characterization of mutant proteins. J Biol Chem 264: 13660-13664.
29. Bugge TH, Flick MJ, Daugherty CC, Degen JL. 1995. Plasminogen deficiency causes severe thrombosis but is compatiblewith development and reproduction. Genes Dev 9: 794-807.
30. Burt DW, Law AS. 1994. Evolution of the transforming growth factor-b superfamily. Prog Growth Factor Res 5: 99-118.
31. Buscemi L, Ramonet D, Klingberg F, Formey A, Smith-Clerc J, Meister JJ, Hinz B. 2011. The single-molecule mechanics of the latent TGF-β1 complex. Curr Biol 21: 2046-2054.
32. Cambier S, Gline S, Mu D, Collins R, Araya J, Dolganov G, Einheber S, Boudreau N, Nishimura SL. 2005. Integrin avb8-mediated activation of transforming growth factor-b by perivascular astrocytes: An angiogenic control switch. Am J Pathol 166: 1883-1894.
33. Carlson CM, Turpin EA, Moser LA, O’Brien KB, Cline TD, Jones JC, Tumpey TM, Katz JM, Kelley LA, Gauldie J, et al. 2010. Transforming growth factor-b: Activation by neuraminidase and role in highly pathogenic H5N1 influenza pathogenesis. PLoS Pathog 6: e1001136.
34. Chen Y, Ali T, Todorovic V, O’Leary JM, Kristina Downing A, Rifkin DB. 2005. Amino acid requirements for formation of the TGF-β-latent TGF-β-binding protein complexes. J Mol Biol 345: 175-186.
35. Chen Q, Sivakumar P, Barley C, Peters DM, Gomes RR, Farach-Carson MC, Dallas SL. 2007. Potential role for heparan sulfate proteoglycans in regulation of transforming growth factor-b (TGF-β) by modulating assembly of latent TGF-β-binding protein-1. J Biol Chem 282: 26418-26430.
36. Cohn RD, van Erp C, Habashi JP, Soleimani AA, Klein EC, Lisi MT, Gamradt M, ap Rhys CM, Holm TM, Loeys BL, et al. 2007. Angiotensin II type 1 receptor blockade attenuates TGF-β-induced failure of muscle regeneration in multiple myopathic states. Nat Med 13: 204-210.
37. Colarossi C, Chen Y, Obata H, Jurukovski V, Fontana L, Dabovic B, Rifkin DB. 2005. Lung alveolar septation defects in Ltbp-3-null mice. Am J Pathol 167: 419-428.
38. Cook JR, Clayton NP, Carta L, Galatioto J, Chiu E, Smaldone S, Nelson CA, Cheng SH, Wentworth BM, Ramirez F. 2015. Dimorphic effects of transforming growth factorb signaling during aortic aneurysm progression in mice suggest a combinatorial therapy for Marfan syndrome. Arterioscler Thromb Vasc Biol 35: 911-917.
39. Crawford SE, Stellmach V, Murphy-Ullrich JE, Ribeiro SM, Lawler J, Hynes RO, Boivin GP, Bouck N. 1998. Thrombospondin-1 is a major activator of TGF-β1 in vivo. Cell 93: 1159-1170.
40. Cuende J, Lienart S, Dedobbeleer O, van der Woning B, De Boeck G, Stockis J, Huygens C, Colau D, Somja J, Delvenne P, et al. 2015. Monoclonal antibodies against GARP/TGF-β1 complexes inhibit the immunosuppressive activity of human regulatory T cells in vivo. Sci Transl Med 7: 284ra256.
41. Dabovic B, Chen Y, Colarossi C, Obata H, Zambuto L, Perle MA, Rifkin DB. 2002. Bone abnormalities in latent TGF β-binding protein (Ltbp)-3-null mice indicate a role for Ltbp-3 in modulating TGF-β bioavailability. J Cell Biol 156: 227-232.
42. Dabovic B, Chen Y, Choi J, Vassallo M, Dietz HC, Ramirez F, von Melchner H, Davis EC, Rifkin DB. 2009. Dual functions for LTBP in lung development: LTBP-4 independently modulates elastogenesis and TGF-β activity. J Cell Physiol 219: 14-22.
43. Dabovic B, Chen Y, Choi J, Davis EC, Sakai LY, Todorovic V, Vassallo M, Zilberberg L, Singh A, Rifkin DB. 2011. Control of lung development by latent TGF-β-binding proteins. J Cell Physiol 226: 1499-1509.
44. Dabovic B, Robertson IB, Zilberberg L, Vassallo M, Davis EC, Rifkin DB. 2014. Function of latent TGF-β-binding protein 4 and fibulin 5 in elastogenesis and lung development. J Cell Physiol 230: 226-236.
45. Dallas SL, Park-Snyder S, Miyazono K, Twardzik D, Mundy GR, Bonewald LF. 1994. Characterization and autoregulation of latent transforming growth factor b (TGF-β) complexes in osteoblast-like cell lines. Production of a latent complex lacking the latent TGF-β-binding protein. J Biol Chem 269: 6815-6821.
46. Dallas SL, Sivakumar P, Jones CJ, Chen Q, Peters DM, Mosher DF, Humphries MJ, Kielty CM. 2005a. Fibronectin regulates latent transforming growth factor-b (TGF-β) by controlling matrix assembly of latent TGF-β-binding protein-1. J Biol Chem 280: 18871-18880.
47. Dallas SL, Zhao S, Cramer SD, Chen Z, Peehl DM, Bonewald LF. 2005b. Preferential production of latent transforming growth factor b-2 by primary prostatic epithelial cells and its activation by prostate-specific antigen. J Cell Physiol 202: 361-370.
48. Dennis PA, Rifkin DB. 1991. Cellular activation of latent transforming growth factor b requires binding to the cation-independent mannose 6-phosphate/insulin-like growth factor type II receptor. Proc Natl Acad Sci 88: 580-584.
49. Drews F, Knobel S, Moser M, Muhlack KG, Mohren S, Stoll C, Bosio A, Gressner AM, Weiskirchen R. 2008. Disruption of the latent transforming growth factor-b-binding protein-1 gene causes alteration in facial structure and influences TGF-β bioavailability. Biochim Biophys Acta 1783: 34-48.
50. Dubois CM, Laprise MH, Blanchette F, Gentry LE, Leduc R. 1995. Processing of transforming growth factor b1 precursor by human furin convertase. J Biol Chem 270: 10618-10624.
51. Dunker N, Krieglstein K. 2002. Tgfb22/2 Tgfb32/2 double knockout mice display severe midline fusion defects and early embryonic lethality. Anat Embryol (Berl) 206: 73-83.
52. Edwards JP, Thornton AM, Shevach EM. 2014. Release of active TGF-β1 from the latent TGF-β1/GARP complex on Tregulatory cells is mediated by integrin b8. J Immunol 193: 2843-2849.
53. Ehrhart EJ, Segarini P, Tsang ML, Carroll AG, Barcellos-Hoff MH. 1997. Latent transforming growth factor b1 activation in situ: Quantitative and functional evidence after low-dose g-irradiation. FASEB J 11: 991-1002.
54. Emami N, Diamandis EP. 2010. Potential role of multiple members of the kallikrein-related peptidase family of serine proteases in activating latent TGF b1 in semen. Biol Chem 391: 85-95.
55. Fava RA, McClure DB. 1987. Fibronectin-associated transforming growth factor. J Cell Physiol 131: 184-189.
56. Fjellbirkeland L, Cambier S, Broaddus VC, Hill A, Brunetta P, Dolganov G, Jablons D, Nishimura SL. 2003. Integrin avb8-mediated activation of transforming growth factor-b inhibits human airway epithelial proliferation in intact bronchial tissue. Am J Pathol 163: 533-542.
57. Flaumenhaft R, Abe M, Sato Y, Miyazono K, Harpel J, Heldin CH, Rifkin DB. 1993. Role of the latent TGF-β-binding protein in the activation of latent TGF-β by co-cultures of endothelial and smooth muscle cells. J Cell Biol 120: 995-1002.
58. Fontana L, Chen Y, Prijatelj P, Sakai T, Fassler R, Sakai LY, Rifkin DB. 2005. Fibronectin is required for integrin avb6-mediated activation of latent TGF-β complexes containing LTBP-1. FASEB J 19: 1798-1808.
59. Ganesh SK, Morissette R, Xu Z, Schoenhoff F, Griswold BF, Yang J, Tong L, Yang ML, Hunker K, Sloper L, et al. 2014. Clinical and biochemical profiles suggest fibromuscular dysplasia is a systemic disease with altered TGF-β expression and connective tissue features. FASEB J 28: 3313-3324.
60. Garg P, Vijay-Kumar M, Wang L, Gewirtz AT, Merlin D, Sitaraman SV. 2009.Matrix metalloproteinase-9-mediated tissue injury overrides the protective effect of matrix metalloproteinase-2 during colitis. Am J Physiol Gastrointest Liver Physiol 296: G175-G184.
61. Gazzerro E, Canalis E. 2006. Bone morphogenetic proteins and their antagonists. Rev Endocr Metab Disord 7: 51-65.
62. Ge G, Greenspan DS. 2006. BMP1 controls TGFb1 activation via cleavage of latent TGF-β-binding protein. J Cell Biol 175: 111-120.
63. Gentry LE, Nash BW. 1990. The pro-domain of pre-protransforming growth factor b1 when independently expressed as a functional binding protein for the mature growth factor. Biochemistry 29: 6851-6857.
64. Gleizes PE, Beavis RC, Mazzieri R, Shen B, Rifkin DB. 1996. Identification and characterization of an eight-cysteine repeat of the latent transforming growth factor-b-binding protein-1 that mediates bonding to the latent transforming growth factor-b1. J Biol Chem 271: 29891-29896.
65. Glinka Y, Prud’homme GJ. 2008. Neuropilin-1 is a receptor for transforming growth factor b-1, activates its latent form, and promotes regulatory T cell activity. J Leukoc Biol 84: 302-310.
66. Glinka Y, Stoilova S, Mohammed N, Prud’homme GJ. 2011. Neuropilin-1 exerts co-receptor function for TGF-β-1 on the membrane of cancer cells and enhances responses to both latent and active TGF-β. Carcinogenesis 32: 613-621.
67. Grafe I, Yang T, Alexander S, Homan EP, Lietman C, Jiang MM, Bertin T, Munivez E, Chen Y, Dawson B, et al. 2014. Excessive transforming growth factor-b signaling is a common mechanism in osteogenesis imperfecta. Nat Med 20: 670-675.
68. Grainger DJ, Frow EK. 2000. Thrombospondin 1 does not activate transforming growth factor b1 in a chemically defined system or in smooth-muscle-cell cultures. Biochem J 350: 291-298.
69. Grandclement C, Pallandre JR, Valmary Degano S, Viel E, Bouard A, Balland J, Remy-Martin JP, Simon B, Rouleau A, Boireau W, et al. 2011. Neuropilin-2 expression promotes TGF-β1-mediated epithelial to mesenchymal transition in colorectal cancer cells. PLoS ONE 6: e20444.
70. Gregory KE, Ono RN, Charbonneau NL, Kuo CL, Keene DR, Bachinger HP, Sakai LY. 2005. The prodomain of BMP-7 targets the BMP-7 complex to the extracellular matrix. J Biol Chem 280: 27970-27980.
71. Habashi JP, Judge DP, Holm TM, Cohn RD, Loeys BL, Cooper TK, Myers L, Klein EC, Liu G, Calvi C, et al. 2006. Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science 312: 117-121.
72. Habashi JP, Doyle JJ, Holm TM, Aziz H, Schoenhoff F, Bedja D, Chen Y, Modiri AN, Judge DP, Dietz HC. 2011. Angiotensin II type 2 receptor signaling attenuates aortic aneurysm in mice through ERK antagonism. Science 332: 361-365.
73. Hara M, Kirita A, Kondo W, Matsuura T, Nagatsuma K, Dohmae N, Ogawa S, Imajoh-Ohmi S, Friedman SL, Rifkin DB, et al. 2014. LAP degradation product reflects plasma kallikrein-dependent TGF-β activation in patients with hepatic fibrosis. Springerplus 3: 221.
74. Henderson NC, Arnold TD, Katamura Y, Giacomini MM, Rodriguez JD, McCarty JH, Pellicoro A, Raschperger E, Betsholtz C, Ruminski PG, et al. 2013. Targeting of av integrin identifies a core molecular pathway that regulates fibrosis in several organs. Nat Med 19: 1617-1624.
75. Herpin A, Lelong C, Favrel P. 2004. Transforming growth factor-b-related proteins: An ancestral and widespread superfamily of cytokines in metazoans. Dev Comp Immunol 28: 461-485.
76. Hildebrand A, Romaris M, Rasmussen LM, Heinegard D, Twardzik DR, Border WA, Ruoslahti E. 1994. Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor b. Biochem J 302: 527-534.
77. Hinck AP, Mueller TD, Springer T. 2016. Structural basis of growth factor-receptor, growth factor-prodomain, growth factor-modulator interactions, and functional implications for signaling. Cold Spring Harb Perspect Biol doi: 10.1101/cshperspect.a022103.
78. Hinz B. 2013. It has to be the av: Myofibroblast integrins activate latent TGF-β1. Nat Med 19: 1567-1568.
79. Holmbeck K, Bianco P, Caterina J, Yamada S, Kromer M, Kuznetsov SA, Mankani M, Robey PG, Poole AR, Pidoux I, et al. 1999. MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover. Cell 99: 81-92.
80. Horiguchi M, Todorovic V, Hadjiolova K, Weiskirchen R, Rifkin DB. 2015. Abrogation of both short and long forms of latent transforming growth factor-b-binding protein-1 causes defective cardiovascular development and is perinatally lethal. Matrix Biol 43: 61-70.
81. Hyytiainen M, Penttinen C, Keski-Oja J. 2004. Latent TGFb-binding proteins: Extracellular matrix association and roles in TGF-β activation. Crit Rev Clin Lab Sci 41: 233-264.
82. Inoue T, Ohbayashi T, Fujikawa Y, Yoshida H, Akama TO, Noda K, Horiguchi M, Kameyama K, Hata Y, Takahashi K, et al. 2014. Latent TGF-β-binding protein-2 is essential for the development of ciliary zonule microfibrils. Hum Mol Genet 23: 5672-5682.
83. Isaka Y, Brees DK, Ikegaya K, Kaneda Y, Imai E, Noble NA, Border WA. 1996. Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney. Nat Med 2: 418-423.
84. Isogai Z, Ono RN, Ushiro S, Keene DR, Chen Y, Mazzieri R, Charbonneau NL, Reinhardt DP, Rifkin DB, Sakai LY. 2003. Latent transforming growth factor b-binding protein 1 interacts with fibrillin and is a microfibril-associated protein. J Biol Chem 278: 2750-2757.
85. Janssens K, ten Dijke P, Ralston SH, Bergmann C, Van Hul W. 2003. Transforming growth factor-b1 mutations in Camurati-Engelmann disease lead to increased signaling by altering either activation or secretion of the mutant protein. J Biol Chem 278: 7718-7724.
86. Jenkins G. 2008. The role of proteases in transforming growth factor-b activation. Int J Biochem Cell Biol 40: 1068-1078.
87. Jensen SA, Robertson IB, Handford PA. 2012. Dissecting the fibrillin microfibril: Structural insights into organization and function. Structure 20: 215-225.
88. Jobling MF, Mott JD, Finnegan MT, Jurukovski V, Erickson AC, Walian PJ, Taylor SE, Ledbetter S, Lawrence CM, Rifkin DB, Barcellos-Hoff MH. 2006. Isoform-specific activation of latent transforming growth factor b (LTGF-β) by reactive oxygen species. Radiat Res 166: 839-848.
89. Johnson JL, Dwivedi A, Somerville M, George SJ, Newby AC. 2011. Matrix metalloproteinase (MMP)-3 activates MMP-9 mediated vascular smooth muscle cell migration and neointima formation in mice. Arterioscler Thromb Vasc Biol 31: e35-e44.
90. Judge DP, Biery NJ, Keene DR, Geubtner J, Myers L, Huso DL, Sakai LY, Dietz HC. 2004. Evidence for a critical contribution of haploinsufficiency in the complex pathogenesis ofMarfan syndrome. J Clin Invest 114: 172-181.
91. Jullien P, Berg TM, Lawrence DA. 1989. Acidic cellular environments: Activation of latent TGF-β and sensitization of cellular responses to TGF-β and EGF. Int J Cancer 43: 886-891.
92. Kantola AK, Keski-Oja J, Koli K. 2008. Fibronectin and heparin-binding domains of latent TGF-β-binding protein (LTBP)-4 mediate matrix targeting and cell adhesion. Exp Cell Res 314: 2488-2500.
93. Kantola AK, Ryynanen MJ, Lhota F, Keski-Oja J, Koli K. 2010. Independent regulation of short and long forms of latent TGF-β-binding protein (LTBP)-4 in cultured fibroblasts and human tissues. J Cell Physiol 223: 727-736.
94. Kast J, Hanecker P, Beaufort N, Giese A, Joutel A, Dichgans M, Opherk C, Haffner C. 2014. Sequestration of latent TGF-β-binding protein 1 into CADASIL-related Notch3-ECD deposits. Acta Neuropathol Commun 2: 96.
95. Kaur J, Reinhardt DP. 2012. Immobilized metal affinity chromatography co-purifies TGF-β1 with histidinetagged recombinant extracellular proteins. PLoS ONE 7: e48629.
96. Kim KK, Sheppard D, Chapman HA. 2016. TGF-β signaling and tissue fibrosis. Cold Spring Harb Perspect Biol doi: 10.1101/cshperspect.a022293.
97. Kinsey R, Williamson MR, Chaudhry S, Mellody KT, Mc-Govern A, Takahashi S, Shuttleworth CA, Kielty CM. 2008. Fibrillin-1 microfibril deposition is dependent on fibronectin assembly. J Cell Sci 121: 2696-2704.
98. Kitamura H, Cambier S, Somanath S, Barker T, Minagawa S, Markovics J, Goodsell A, Publicover J, Reichardt L, Jablons D, et al. 2011. Mouse and human lung fibroblasts regulate dendritic cell trafficking, airway inflammation, and fibrosis through integrin avb8-mediated activation of TGF-β. J Clin Invest 121: 2863-2875.
99. Klingberg F, Chow ML, Koehler A, Boo S, Buscemi L, Quinn TM, Costell M, Alman BA, Genot E, Hinz B. 2014. Prestress in the extracellular matrix sensitizes latent TGF-β1 for activation. J Cell Biol 207: 283-297.
100. Kojima S, Rifkin DB. 1993.Mechanism of retinoid-induced activation of latent transforming growth factor-b in bovine endothelial cells. J Cell Physiol 155: 323-332.
101. Koli K, Hyytiainen M, Ryynanen MJ, Keski-Oja J. 2005. Sequential deposition of latent TGF-β-binding proteins (LTBPs) during formation of the extracellular matrix in human lung fibroblasts. Exp Cell Res 310: 370-382.
102. Kottmann RM, Kulkarni AA, Smolnycki KA, Lyda E, Dahanayake T, Salibi R, Honnons S, Jones C, Isern NG, Hu JZ, et al. 2012. Lactic acid is elevated in idiopathic pulmonary fibrosis and induces myofibroblast differentiation via pH-dependent activation of transforming growth factor-b. Am J Respir Crit Care Med 186: 740-751.
103. Kulkarni AB, Huh CG, Becker D, Geiser A, Lyght M, Flanders KC, Roberts AB, Sporn MB, Ward JM, Karlsson S. 1993. Transforming growth factor b1-null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci 90: 770-774.
104. LaMarre J, Wollenberg GK, Gauldie J, Hayes MA. 1990. a2-Macroglobulin and serum preferentially counteract the mitoinhibitory effect of transforming growth factor-b2 in rat hepatocytes. Lab Invest 62: 545-551.
105. LaMarre J, Hayes MA, Wollenberg GK, Hussaini I, Hall SW, Gonias SL. 1991. An a2-macroglobulin receptor-dependent mechanism for the plasma clearance of transforming growth factor-b1 in mice. J Clin Invest 87: 39-44.
106. Lawler J, Sunday M, Thibert V, Duquette M, George EL, Rayburn H, Hynes RO. 1998. Thrombospondin-1 is required for normal murine pulmonary homeostasis and its absence causes pneumonia. J Clin Invest 101: 982-992.
107. Le Goff C, Cormier-Daire V. 2012. From tall to short: The role of TGFb signaling in growth and its disorders. Am J Med Genet C Semin Med Genet 160C: 145-153.
108. Le Goff C, Mahaut C, Wang LW, Allali S, Abhyankar A, Jensen S, Zylberberg L, Collod-Beroud G, Bonnet D, Alanay Y, et al. 2011. Mutations in the TGF-β-binding protein-like domain 5 of FBN1 are responsible for acromicric and geleophysic dysplasias. Am J Hum Genet 89: 7-14.
109. Leask A, Abraham DJ. 2004. TGF-β signaling and the fibrotic response. FASEB J 18: 816-827.
110. Lee SJ, McPherron AC. 2001. Regulation of myostatin activity and muscle growth. ProcNatl Acad Sci 98: 9306-9311.
111. Lu M, Munger JS, Steadele M, Busald C, Tellier M, Schnapp LM. 2002. Integrin a8b1 mediates adhesion to LAPTGFb1. J Cell Sci 115: 4641-4648.
112. Ludbrook SB, Barry ST, Delves CJ, Horgan CM. 2003. The integrin avb3 is a receptor for the latency-associated peptides of transforming growth factors b1 and b3. Biochem J 369: 311-318.
113. Lyons RM, Keski-Oja J, Moses HL. 1988. Proteolytic activation of latent transforming growth factor-b from fibroblast-conditioned medium. J Cell Biol 106: 1659-1665.
114. Lyons RM, Gentry LE, Purchio AF, Moses HL. 1990. Mechanism of activation of latent recombinant transforming growth factor b1 by plasmin. J Cell Biol 110: 1361-1367.
115. Maeda S, Dean DD, Gay I, Schwartz Z, and Boyan BD. 2001. Activation of latent transforming growth factor b1 by stromelysin 1 in extracts of growth plate chondrocytederived matrix vesicles. J BoneMiner Res 16: 1281-1290.
116. Massam-Wu T, Chiu M, Choudhury R, Chaudhry SS, Baldwin AK, McGovern A, Baldock C, Shuttleworth CA, Kielty CM. 2010. Assembly of fibrillin microfibrils governs extracellular deposition of latent TGF-β. J Cell Sci 123: 3006-3018.
117. Matzuk MM, Lu N, Vogel H, Sellheyer K, Roop DR, Bradley A. 1995. Multiple defects and perinatal death in mice deficient in follistatin. Nature 374: 360-363.
118. McPherron AC, Lawler AM, Lee SJ. 1997. Regulation of skeletal muscle mass in mice by a new TGF-β superfamily member. Nature 387: 83-90.
119. Melton AC, Bailey-Bucktrout SL, Travis MA, Fife BT, Bluestone JA, Sheppard D. 2010. Expression of avb8 integrin on dendritic cells regulates Th17 cell development and experimental autoimmune encephalomyelitis in mice. J Clin Invest 120: 4436-4444.
120. Minagawa S, Lou J, Seed RI, Cormier A, Wu S, Cheng Y, Murray L, Tsui P, Connor J, Herbst R, et al. 2014. Selective targeting of TGF-β activation to treat fibroinflammatory airway disease. Sci Transl Med 6: 241ra279.
121. Miyazono K, Heldin CH. 1989. Role for carbohydrate structures in TGF-β1 latency. Nature 338: 158-160.
122. Miyazono K, Olofsson A, Colosetti P, Heldin CH. 1991. A role of the latent TGF-β1-binding protein in the assembly and secretion of TGF-β1. EMBO J 10: 1091-1101.
123. Mu D, Cambier S, Fjellbirkeland L, Baron JL, Munger JS, Kawakatsu H, Sheppard D, Broaddus VC, Nishimura SL. 2002. The integrin avb8 mediates epithelial homeostasis through MT1-MMP-dependent activation of TGF-β1. J Cell Biol 157: 493-507.
124. Mu Z, Yang Z, Yu D, Zhao Z, Munger JS. 2008. TGFb1 and TGFb3 are partially redundant effectors in brain vascular morphogenesis. Mech Dev 125: 508-516.
125. Mudgett JS, Hutchinson NI, Chartrain NA, Forsyth AJ, McDonnell J, Singer II, Bayne EK, Flanagan J, Kawka D, Shen CF, et al. 1998. Susceptibility of stromelysin 1-deficient mice to collagen-induced arthritis and cartilage destruction. Arthritis Rheum 41: 110-121.
126. Munger JS, Sheppard D. 2011. Cross talk among TGF-β signaling pathways, integrins, and the extracellular matrix. Cold Spring Harb Perspect Biol 3: a005017.
127. Munger JS, Harpel JG, Giancotti FG, Rifkin DB. 1998. Interactions between growth factors and integrins: Latent forms of transforming growth factor-b are ligands for the integrin avb1. Mol Biol Cell 9: 2627-2638.
128. Munger JS, Huang X, Kawakatsu H, Griffiths MJ, Dalton SL, Wu J, Pittet JF, Kaminski N, Garat C, Matthay MA, et al. 1999. The integrin avb6 binds and activates latent TGFb1: A mechanism for regulating pulmonary inflammation and fibrosis. Cell 96: 319-328.
129. Murphy-Ullrich JE, Poczatek M. 2000. Activation of latent TGF-β by thrombospondin-1:Mechanisms and physiology. Cytokine Growth Factor Rev 11: 59-69.
130. Murphy-Ullrich JE, Schultz-Cherry S, Hook M. 1992. Transforming growth factor-b complexes with thrombospondin. Mol Biol Cell 3: 181-188.
131. Neptune ER, Frischmeyer PA, Arking DE, Myers L, Bunton TE, Gayraud B, Ramirez F, Sakai LY, Dietz HC. 2003. Dysregulation of TGF-β activation contributes to pathogenesis in Marfan syndrome. Nat Genet 33: 407-411.
132. Neurohr C, Nishimura SL, Sheppard D. 2006. Activation of transforming growth factor-b by the integrin avb8 delays epithelial wound closure. Am J Respir Cell Mol Biol 35: 252-259.
133. Ng CM, Cheng A, Myers LA, Martinez-Murillo F, Jie C, Bedja D, Gabrielson KL, Hausladen JM, Mecham RP, Judge DP, et al. 2004. TGF-β-dependent pathogenesis of mitral valve prolapse in a mouse model of Marfan syndrome. J Clin Invest 114: 1586-1592.
134. Nistala H, Lee-Arteaga S, Smaldone S, Siciliano G, Carta L, Ono RN, Sengle G, Arteaga-Solis E, Levasseur R, Ducy P, et al. 2010. Fibrillin-1 and-2 differentially modulate endogenous TGF-β and BMP bioavailability during bone formation. J Cell Biol 190: 1107-1121.
135. Noda K, Dabovic B, Takagi K, Inoue T, Horiguchi M, Hirai M, Fujikawa Y, Akama TO, Kusumoto K, Zilberberg L, et al. 2013. Latent TGF-β-binding protein 4 promotes elastic fiber assembly by interacting with fibulin-5. Proc Natl Acad Sci 110: 2852-2857.
136. Nunes I, Shapiro RL, Rifkin DB. 1995. Characterization of latent TGF-β activation by murine peritoneal macrophages. J Immunol 155: 1450-1459.
137. Nunes I, Gleizes PE, Metz CN, Rifkin DB. 1997. Latent transforming growth factor b-binding protein domains involved in activation and transglutaminase-dependent cross-linking of latent transforming growth factor b. J Cell Biol 136: 1151-1163.
138. Oh J, Takahashi R, Adachi E, Kondo S, Kuratomi S, Noma A, Alexander DB, Motoda H, Okada A, Seiki M, et al. 2004. Mutations in two matrix metalloproteinase genes, MMP-2 and MT1-MMP, are synthetic lethal in mice. Oncogene 23: 5041-5048.
139. Olofsson A, Hellman U, Ten Dijke P, Grimsby S, Ichijo H, Moren A, Miyazono K, Heldin CH. 1997. Latent transforming growth factor b complex in Chinese hamster ovary cells contains the multifunctional cysteine-rich fibroblast growth factor receptor, also termed E-selectinligand or MG-160. Biochem J 324: 427-434.
140. Ono RN, Sengle G, Charbonneau NL, Carlberg V, Bachinger HP, Sasaki T, Lee-Arteaga S, Zilberberg L, Rifkin DB, Ramirez F, et al. 2009. Latent transforming growth factor b-binding proteins and fibulins compete for fibrillin-1 and exhibit exquisite specificities in binding sites. J Biol Chem 284: 16872-16881.
141. Oreffo ROC, Mundy GR, Seyedin SM, Bonewald LF. 1989. Activation of the bone-derived latent TGF-β complex by isolated osteoclasts. Biochem Biophys Res Commun 158: 817-823.
142. Pappano WN, Steiglitz BM, Scott IC, Keene DR, Greenspan DS. 2003. Use of Bmp1/Tll1 doubly homozygous null mice and proteomics to identify and validate in vivo substrates of bone morphogenetic protein 1/tolloid-like metalloproteinases. Mol Cell Biol 23: 4428-4438.
143. Paralkar VM, Vukicevic S, Reddi AH. 1991. Transforming growth factor b type 1 binds to collagen IV of basement membrane matrix: Implications for development. Dev Biol 143: 303-308.
144. Penttinen C, Saharinen J, Weikkolainen K, Hyytiainen M, Keski-Oja J. 2002. Secretion of human latent TGF-βbinding protein-3 (LTBP-3) is dependent on co-expression of TGF-β. J Cell Sci 115: 3457-3468.
145. Pociask DA, Sime PJ, Brody AR. 2004. Asbestos-derived reactive oxygen species activate TGF-β1. Lab Invest 84: 1013-1023.
146. Puthawala K, Hadjiangelis N, Jacoby SC, Bayongan E, Zhao Z, Yang Z, Devitt ML, Horan GS, Weinreb PH, Lukashev ME, et al. 2008. Inhibition of integrin avb6, an activator of latent transforming growth factor-b, prevents radiation-induced lung fibrosis. Am J Respir Crit Care Med 177: 82-90.
147. Ramirez F, Rifkin DB. 2009. Extracellular microfibrils: Contextual platforms for TGF-β and BMP signaling. Curr Opin Cell Biol 21: 616-622.
148. Ribeiro SM, Poczatek M, Schultz-Cherry S, Villain M, Murphy-Ullrich JE. 1999. The activation sequence of thrombospondin-1 interacts with the latency-associated peptide to regulate activation of latent transforming growth factor-b. J Biol Chem 274: 13586-13593.
149. Rifkin DB. 2005. Latent transforming growth factor b (TGFb)-binding proteins: Orchestrators of TGF-β availability. J Biol Chem 280: 7409-7412.
150. Robertson IB, Rifkin DB. 2013. Unchaining the beast; insights fromstructural and evolutionary studies on TGF-β secretion, sequestration, and activation. Cytokine Growth Factor Rev 24: 355-372.
151. Robertson I, Jensen S, Handford P. 2011. TB domain proteins: Evolutionary insights into the multifaceted roles of fibrillins and LTBPs. Biochem J 433: 263-276.
152. Robertson IB, Handford PA, Redfield C. 2014. NMR spectroscopic and bioinformatic analyses of the LTBP1 Cterminus reveal a highly dynamic domain organisation. PLoS ONE 9: e87125.
153. Robertson IB, Horiguchi M, Zilberberg L, Dabovic B, Hadjiolova K, Rifkin DB. 2015. Latent TGF-β-binding proteins. Matrix Biol 47: 44-53.
154. Sabatier L, Chen D, Fagotto-Kaufmann C, Hubmacher D, McKee MD, Annis DS, Mosher DF, Reinhardt DP. 2009. Fibrillin assembly requires fibronectin. Mol Biol Cell 20: 846-858.
155. Saharinen J, Keski-Oja J. 2000. Specific sequence motif of 8-Cys repeats of TGF-β-binding proteins, LTBPs, creates a hydrophobic interaction surface for binding of small latent TGF-β. Mol Biol Cell 11: 2691-2704.
156. Saharinen J, Taipale J, Keski-Oja J. 1996. Association of the small latent transforming growth factor-b with an eight cysteine repeat of its binding protein LTBP-1. EMBO J 15: 245-253.
157. Saharinen J, Hyytiainen M, Taipale J, Keski-Oja J. 1999. Latent transforming growth factor-b-binding proteins (LTBPs)—Structural extracellular matrix proteins for targeting TGF-β action. Cytokine Growth Factor Rev 10: 99-117.
158. Saito T, Kinoshita A, Yoshiura K, Makita Y, Wakui K, Honke K, Niikawa N, Taniguchi N. 2001. Domain-specific mutations of a transforming growth factor (TGF)-b1 latency-associated peptide cause Camurati-Engelmann disease because of the formation of a constitutively active form of TGF-β1. J Biol Chem 276: 11469-11472.
159. Sanderson N, Factor V, Nagy P, Kopp J, Kondaiah P, Wakefield L, Roberts AB, Sporn MB, Thorgeirsson SS. 1995. Hepatic expression of mature transforming growth factor b1 in transgenic mice results in multiple tissue lesions. Proc Natl Acad Sci 92: 2572-2576.
160. Sarrazy V, Koehler A, Chow ML, Zimina E, Li CX, Kato H, Caldarone CA, Hinz B. 2014. Integrins avb5 and avb3 promote latent TGF-β1 activation by human cardiac fibroblast contraction. Cardiovasc Res 102: 407-417.
161. Sato Y, Rifkin DB. 1989. Inhibition of endothelial cell movement by pericytes and smooth muscle cells: Activation of a latent transforming growth factor-b1-like molecule by plasmin during co-culture. J Cell Biol 109: 309-315.
162. Schonherr E, Broszat M, Brandan E, Bruckner P, Kresse H. 1998. Decorin core protein fragment Leu155-Val260 interacts with TGF-β but does not compete for decorin binding to type I collagen. Arch Biochem Biophys 355: 241-248.
163. Schultz-Cherry S, Hinshaw VS. 1996. Influenza virus neuraminidase activates latent transforming growth factor b. J Virol 70: 8624-8629.
164. Schultz-Cherry S, Lawler J, Murphy-Ullrich JE. 1994. The type 1 repeats of thrombospondin 1 activate latent transforming growth factor-b. J Biol Chem 269: 26783-26788.
165. Schultz-Cherry S, Chen H, Mosher DF, Misenheimer TM, Krutzsch HC, Roberts DD, Murphy-Ullrich JE. 1995. Regulation of transforming growth factor-b activation by discrete sequences of thrombospondin 1. J Biol Chem 270: 7304-7310.
166. Seliger C, Leukel P, Moeckel S, Jachnik B, Lottaz C, Kreutz M, Brawanski A, Proescholdt M, Bogdahn U, Bosserhoff AK, et al. 2013. Lactate-modulated induction of THBS-1 activates transforming growth factor (TGF)-b2 and migration of glioma cells in vitro. PLoS ONE 8: e78935.
167. Sellheyer K, Bickenbach JR, Rothnagel JA, Bundman D, Longley MA, Krieg T, Roche NS, Roberts AB, Roop DR. 1993. Inhibition of skin development by overexpression of transforming growth factor b1 in the epidermis of transgenic mice. Proc Natl Acad Sci 90: 5237-5241.
168. Sengle G, Charbonneau NL, Ono RN, Sasaki T, Alvarez J, Keene DR, Bachinger HP, Sakai LY. 2008a. Targeting of bone morphogenetic protein growth factor complexes to fibrillin. J Biol Chem 283: 13874-13888.
169. Sengle G, Ono RN, Lyons KM, Bachinger HP, Sakai LY. 2008b. A new model for growth factor activation: Type II receptors compete with the prodomain for BMP-7. J Mol Biol 381: 1025-1039.
170. Sengle G, Ono RN, Sasaki T, Sakai LY. 2011. Prodomains of transforming growth factor b (TGF-β) superfamily members specify different functions: Extracellular matrix interactions and growth factor bioavailability. J Biol Chem 286: 5087-5099.
171. Shi M, Zhu J, Wang R, Chen X, Mi L, Walz T, Springer TA. 2011. Latent TGF-β structure and activation. Nature 474: 343-349.
172. Shibahara K, Ota M, Horiguchi M, Yoshinaga K, Melamed J, Rifkin DB. 2012. Production of gastrointestinal tumors in mice by modulating latent TGF-β1 activation. Cancer Res 73: 459-468.
173. Stach RM, Rowley DA. 1993. A first or dominant immunization. II: Induced immunoglobulin carries transforming growth factor b and suppresses cytolytic T cell responses to unrelated alloantigens. J Exp Med 178: 841-852.
174. Sterner-Kock A, Thorey IS, Koli K, Wempe F, Otte J, Bangsow T, Kuhlmeier K, Kirchner T, Jin S, Keski-Oja J, et al. 2002. Disruption of the gene encoding the latent transforming growth factor b-binding protein 4 (LTBP-4) causes abnormal lung development, cardiomyopathy, and colorectal cancer. Genes Dev 16: 2264-2273.
175. Stickens D, Behonick DJ, Ortega N, Heyer B, Hartenstein B, Yu Y, Fosang AJ, Schorpp-Kistner M, Angel P, Werb Z. 2004. Altered endochondral bone development in matrix metalloproteinase 13-deficient mice. Development 131: 5883-5895.
176. Stockis J, Colau D, Coulie PG, Lucas S. 2009. Membrane protein GARP is a receptor for latent TGF-β on the surface of activated human Treg. Eur J Immunol 39: 3315-3322.
177. Takeuchi Y, Kodama Y, Matsumoto T. 1994. Bone matrix decorin binds transforming growth factor-b and enhances its bioactivity. J Biol Chem 269: 32634-32638.
178. Tatler AL, John AE, Jolly L, Habgood A, Porte J, Brightling C, Knox AJ, Pang L, Sheppard D, Huang X, et al. 2011. Integrin avb5-mediated TGF-β activation by airway smooth muscle cells in asthma. J Immunol 187: 6094-6107.
179. Teicher BA, Ikebe M, Ara G, Keyes SR, Herbst RS. 1997. Transforming growth factor-b1 overexpression produces drug resistance in vivo: Reversal by decorin. In Vivo 11: 463-472.
180. Teitelbaum SL. 2000. Bone resorption by osteoclasts. Science 289: 1504-1508.
181. Todorovic V, Rifkin DB. 2012. LTBPs, more than just an escort service. J Cell Biochem 113: 410-418.
182. Todorovic V, Frendewey D, Gutstein DE, Chen Y, Freyer L, Finnegan E, Liu F, Murphy A, Valenzuela D, Yancopoulos G, et al. 2007. Long form of latent TGF-β-binding protein 1 (Ltbp1L) is essential for cardiac outflow tract septation and remodeling. Development 134: 3723-3732.
183. Todorovic V, Finnegan E, Freyer L, Zilberberg L, Ota M, Rifkin DB. 2011. Long form of latent TGF-β-binding protein 1 (Ltbp1L) regulates cardiac valve development. Dev Dyn 240: 176-187.
184. Tran DQ, Andersson J, Wang R, Ramsey H, Unutmaz D, Shevach EM. 2009. GARP (LRRC32) is essential for the surface expression of latent TGF-β on platelets and activated FOXP3þ regulatory T cells. Proc Natl Acad Sci 106: 13445-13450.
185. Travis MA, Reizis B, Melton AC, Masteller E, Tang Q, Proctor JM, Wang Y, Bernstein X, Huang X, Reichardt LF, et al. 2007. Loss of integrin avb8 on dendritic cells causes autoimmunity and colitis in mice. Nature 449: 361-365.
186. Umans L, Serneels L, Overbergh L, Lorent K, Van Leuven F, Van den Berghe H. 1995. Targeted inactivation of the mouse a2-macroglobulin gene. J Biol Chem 270: 19778-19785.
187. Unsold C, Hyytiainen M, Bruckner-Tuderman L, Keski-Oja J. 2001. Latent TGF-β-binding protein LTBP-1 contains three potential extracellular matrix interacting domains. J Cell Sci 114: 187-197.
188. Urban Z, Hucthagowder V, Schurmann N, Todorovic V, Zilberberg L, Choi J, Sens C, Brown CW, Clark RD, Holland KE, et al. 2009. Mutations in LTBP4 cause a syndrome of impaired pulmonary, gastrointestinal, genitourinary, musculoskeletal, and dermal development. Am J Hum Genet 85: 593-605.
189. Vitt UA, Hsu SY, Hsueh AJ. 2001. Evolution and classification of cystine knot-containing hormones and related extracellular signaling molecules. Mol Endocrinol 15: 681-694.
190. Walton KL, Makanji Y, Chen J, Wilce MC, Chan KL, Robertson DM, Harrison CA. 2010. Two distinct regions of latency-associated peptide coordinate stability of the latent transforming growth factor-b1 complex. J Biol Chem 285: 17029-17037.
191. Walton KL, Makanji Y, Harrison CA. 2011. New insights into the mechanisms of activin action and inhibition. Mol Cell Endocrinol 359: 2-12.
192. Wang H, Kochevar IE. 2005. Involvement of UVB-induced reactive oxygen species in TGF-β biosynthesis and activation in keratinocytes. Free Radic BiolMed 38: 890-897.
193. Wang R, Wan Q, Kozhaya L, Fujii H, Unutmaz D. 2008. Identification of a regulatory T cell specific cell-surface molecule that mediates suppressive signals and induces Foxp3 expression. PLoS ONE 3: e2705.
194. Wang R, Zhu J, Dong X, Shi M, Lu C, Springer TA. 2012. GARP regulates the bioavailability and activation of TGF-β. Mol Biol Cell 23: 1129-1139.
195. Winbanks CE, Weeks KL, Thomson RE, Sepulveda PV, Beyer C, Qian H, Chen JL, Allen JM, Lancaster GI, Febbraio MA, et al. 2012. Follistatin-mediated skeletal muscle hypertrophy is regulated by Smad3 and mTOR independently of myostatin. J Cell Biol 197: 997-1008.
196. Wipff PJ, Hinz B. 2008. Integrins and the activation of latent transforming growth factor b1-An intimate relationship. Eur J Cell Biol 87: 601-615.
197. Wipff PJ, Rifkin DB, Meister JJ, Hinz B. 2007.Myofibroblast contraction activates latent TGF-β1 from the extracellular matrix. J Cell Biol 179: 1311-1323.
198. Worthington JJ, Kelly A, Smedley C, Bauche D, Campbell S, Marie JC, Travis MA. 2015. Integrin avb8-mediated TGF-β activation by effector regulatory T cells is essential for suppression of T-cell-mediated inflammation. Immunity 42: 903-915.
199. Yadin DA, Robertson IB, McNaught-Davis J, Evans P, Stoddart D, Handford PA, Jensen SA, Redfield C. 2013. Structure of the fibrillin-1 N-terminal domains suggests that heparan sulfate regulates the early stages of microfibril assembly. Structure 21: 1743-1756.
200. Yamazaki S, Ema H, Karlsson G, Yamaguchi T, Miyoshi H, Shioda S, Taketo MM, Karlsson S, Iwama A, Nakauchi H. 2011. Nonmyelinating Schwann cells maintain hematopoietic stem cell hibernation in the bone marrow niche. Cell 147: 1146-1158.
201. Yang LT, Kaartinen V. 2007. Tgfb1 expressed in the Tgfb3 locus partially rescues the cleft palate phenotype of Tgfb3 null mutants. Dev Biol 312: 384-395.
202. Yang Y, Dignam JD, Gentry LE. 1997. Role of carbohydrate structures in the binding of b1-latency-associated peptide to ligands. Biochemistry 36: 11923-11932.
203. Yang Z, Mu Z, Dabovic B, Jurukovski V, Yu D, Sung J, Xiong X, Munger JS. 2007. Absence of integrin-mediated TGFb1 activation in vivo recapitulates the phenotype of TGF-β1-null mice. J Cell Biol 176: 787-793.
204. Yang T, Mendoza-Londono R, Lu H, Tao J, Li K, Keller B, Jiang MM, Shah R, Chen Y, Bertin TK, et al. 2010. Eselectin ligand-1 regulates growth plate homeostasis in mice by inhibiting the intracellular processing and secretion of mature TGF-β. J Clin Invest 120: 2474-2485.
205. Yehualaeshet T, O’Connor R, Green-Johnson J, Mai S, Silverstein R, Murphy-Ullrich JE, Khalil N. 1999. Activation of rat alveolar macrophage-derived latent transforming growth factor b1 by plasmin requires interaction with thrombospondin-1 and its cell-surface receptor, CD36. Am J Pathol 155: 841-851.
206. Yoshinaga K, Obata H, Jurukovski V, Mazzieri R, Chen Y, Zilberberg L, Huso D, Melamed J, Prijatelj P, Todorovic V, et al. 2008. Perturbation of transforming growth factor (TGF)-b1 association with latent TGF-β-binding protein yields inflammation and tumors. Proc Natl Acad Sci 105: 18758-18763.
207. Yu Q, Stamenkovic I. 2000. Cell-surface-localized matrix metalloproteinase-9 proteolytically activates TGF-β and promotes tumor invasion and angiogenesis. Genes Dev 14: 163-176.
208. Zhou Y, Cashman TJ, Nevis KR, Obregon P, Carney SA, Liu Y, Gu A, Mosimann C, Sondalle S, Peterson RE, et al. 2011. Latent TGF-β-binding protein 3 identifies a second heart field in zebrafish. Nature 474: 645-648.
209. Zilberberg L, Todorovic V, Dabovic B, Horiguchi M, Courousse T, Sakai LY, Rifkin DB. 2012. Specificity of latent TGF-β-binding protein (LTBP) incorporation into matrix: Role of fibrillins and fibronectin. J Cell Physiol 227: 3828-3836.
210. Zilberberg L, Phoon CK, Robertson I, Dabovic B, Ramirez F, Rifkin DB. 2015. Genetic analysis of the contribution of LTBP-3 to thoracic aneurysm in Marfan syndrome. Proc Natl Acad Sci 112: 14012-14017.